Buy Vytorin through the unique service that maximize your savings

WASHINGTON — The House Energy and Commerce Committee wants the Food and Drug Administration to turn over the results of an analysis about the potential links between cancer and the cholesterol drug Vytorin, which is sold jointly by Merck & Co. and Schering-Plough Corp.
A recent study indicated that Vytorin not only failed to help people with heart value disease avoid further problems but also appeared to increase their risk of cancer.
The study, known …